• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVR
Click for more information
1.61% $15.25

ANTERIS TECHNOLOGIES LTD - Charts / Financials

Market Cap $322.3M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Anteris Technologies Ltd is an Australia-based structural heart company. The Company is... Anteris Technologies Ltd is an Australia-based structural heart company. The Company is engaged in designing, developing, and commercializing medical devices. The Company’s lead product, DurAVR, is a transcatheter heart valve (THV) for treating aortic stenosis. DurAVR THV is made using ADAPT tissue, its patented anti-calcification tissue technology. DurAVR THV is a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue. It is designed to mimic the performance of a pre-disease human aortic valve. Its balloon expandable ComASUR Delivery System provides controlled deployment and accurate placement of the DurAVR THV valve, designed to achieve precise alignment with the heart’s native commissures to achieve ideal valve positioning.More

refresh Created with Sketch. REFRESH
Last update - 16.20pm 23/08/2024 (20 minute delay) ?
Day
Open $15.50   Day High $15.50   Day Low $14.80
Daily Volume 9315
Bids   Sellers
Number Price Volume   Number Price Volume
1 $15.00 297   2 $15.25 1300

Directors & Senior Management

Mr. Wayne G. Paterson Chief Executive Officer, Managing Director, Executive Director
Mr. Matthew Mcdonnell Chief Financial Officer
Mr. David St. Denis Chief Operating Officer
Dr. Chris Meduri Chief Medical Officer
Mr. John Seaberg Non-Executive Independent Chairman of the Board
Mr. Stephen Denaro Company Secretary, Non-Executive Independent Director
Dr. Wenyi Gu Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
$15.25 		Change
-0.250(1.61%) 		Mkt cap ! $322.3M
Open High Low Value Volume
$15.50 $15.50 $14.80 $140.4K 9.315K

Buyers (Bids)

No. Vol. Price($)
1 297 $15.00
 

Sellers (Offers)

Price($) Vol. No.
$15.25 1300 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?

Top Stories

Reporting wrap: Inghams, Accent, Mayne Pharma

Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
The business of sport: Warren Tredrea's take on this week's news Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.